Jack Bendheim, President and CEO, 10% Owner at PHIBRO ANIMAL HEALTH CORP (PAHC), sold 12,584 shares at $40.98 ($530K) on 2025-11-05, disclosed to the SEC on 2025-11-06.
Scheduled sale ($530k) by President and CEO, 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $43.01 | 2,996 | $129K | 24.3% |
| 2 | $43.01 | 2,996 | $129K | 24.3% |
| 3 | $43.62 | 524 | $23K | 4.3% |
| 4 | $40.98 | 2,548 | $104K | 19.7% |
| 5 | $40.98 | 2,548 | $104K | 19.7% |
| 6 | $41.83 | 972 |
| $41K |
| 7.7% |
| Total | $42.12 avg | 12,584 | $530K | 100% |
| Filing → |
| PAHC | SELL | 2026-04-23 | $1.2M | — | Filing → |
| PAHC | SELL | 2026-04-16 | $1.2M | — | Filing → |
| PAHC | SELL | 2026-03-31 | $1.5M | — | Filing → |